asct Weekly Update MultiBriefs
Subscribe
Contact Us
Media Kit

Browse Categories

Browse by Date

HIPAA turns 20: A look back at its impact

In August 1996, the Health Insurance Portability and Accountability Act — more commonly known as HIPAA — was signed into law by then-President Bill Clinton. Twenty years later, with Clinton's wife possibly on the verge of a presidency of her own, HIPAA still...

source: By Scott E. Rupp
read more
Search past issues
Search products and services

Always and Never: Words not meant for the practice of medicine, the laboratory, or a pandemic

As a first-year medical student, once a week my small group would meet with an attending physician to learn how to talk to patients respectfully and document that conversation in the history and physical examination. In...

source: CAP Today
read more

Medical practitioner expresses grave concern over women presenting with cervical cancer

One medical professional is calling on women to not only get their annual check-ups but to speak to their doctors about cervical cancer screening. Obstetrician and gynecologist at the Sir Lester Bird Medical Centre, Dr. Cherie...

source: Newsco Observer
read more

Risk assessment of pulmonary metastasis for cervical cancer patients by ensemble learning models: A large population based real-world study

Pulmonary metastasis (PM) is an independent risk factor affecting the prognosis of cervical patients, but it still lacks a prediction. This study aimed to develop machine learning-based predictive models for PM.

source: Dovepress
read more

Researchers discover new link between CRISPR, p53 and cancer

The new findings suggest that inhibiting p53 can reduce CRISPR-associated cancer risks and may lead to developments in precision medicine.

source: Drug Target Review
read more

Happy Thanksgiving

This year, as we celebrate Thanksgiving, we at ASCT want you to know that we are grateful for you, our...

source:
read more

Residual cancer burden offers predictive response measure across breast cancer subtypes

Measurement of residual cancer burden served as both an accurate and consistent indicator of prognosis across breast cancer subtypes, according to an analysis of data from the randomized I-SPY2 trial published in JAMA Oncology.

source: Healio
read more

RECOMMENDED:

Powered by MultiBriefs
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063

Subscribe to ASCT Viewpoint

*Email:
*First Name:
*Last Name:
*Company:
Title:
Street Address:
City:
State / Province:
Zip / Postal Code:
Country:
Are you a member of ASCT? Yes   No
Privacy Policy
X